Delivery Order SPE2DB20D3104-SPE2DB23FV4Q5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.26 firm fixed-price delivery order is for the supply of CORLANOR 7.5 MG TABLET 60S, a medication used to treat heart failure. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the procurement of CORLANOR 5 MG TABLET 60S by the Defense Logistics Agency (DLA), a defense agency. The $2,325.52 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 14, 2024, with a completion date of May 15, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,099.69 firm fixed-price contract is for the delivery of CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 11, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award is for the delivery of CORLANOR 7.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,733.87, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 8, 2023. The contract was awarded on November 7, 2023 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,898.14 firm fixed-price delivery order contract is for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion date of January 9, 2024 and does not...
- This federal contract award is for the delivery of CORLANOR 5MG 60S pharmaceutical products, valued at $10,035.49. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. The IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $5,465.20 firm fixed price delivery order is for the supply of CORLANOR 5 MG TABLET 60S, a medication, with a performance period extending through June 13, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $1,341.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORLANOR 7.5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025, and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $1,162.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $6,325.95 delivery order contract is for the supply of CORLANOR 7.5 MG TABLET 60S, a cardiovascular medication. There is no set-aside designation, indicating this was a full and open competition. The contract has an ultimate completion date of October 17, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB23FV4Q5Delivery Order
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of CORLANOR 7.5 MG TABLET 60S, a pharmaceutical product. The $1,430.64 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 10, 2023, with a completion date of January 11, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that larger IDC mechanism, enabling efficient government procurement of essential medications for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/10/23 |